GAP
Exceptional Clinical Trial Volunteers Presented National Citizen Scientist Awards for Research Efforts
The Global Alzheimer’s Platform Foundation’s® (GAP) 2025 Citizen Scientist Award® recipients announced in Las Vegas WASHINGTON, DC (Feb. 27, 2026) — Today, the Global Alzheimer’s Platform Foundation (GAP) proudly announced the 2025 National Citizen Scientist Awards® elevated honorees. GAP’s Citizen Scientist Awards (CSA) acknowledge the contributions of individuals who make a difference by volunteering in clinical trials for neurodegenerative diseases. This year’s award […]
Global Healthcare Magazine: Building Healthcare Companies With Purpose and Precision
Long before Alzheimer’s disease became a global crisis, it was already shaping quiet, devastating stories inside individual families. Science was fragmented. Treatments were elusive. And for decades, progress moved more slowly than anyone anticipated. For entrepreneurs working in healthcare, the challenge was not just scientific. It was structural. How do you build companies that can […]
Archynewsy: Alzheimer’s Research Advances: Global Alzheimer’s Platform Foundation Conference in Las Vegas
Las Vegas is set to host a significant gathering of Alzheimer’s and Parkinson’s disease research leaders this week, as the Global Alzheimer’s Platform Foundation (GAP) convenes its annual conference from February 25th through February 27th at the Red Rock Casino Resort & Spa. The event will bring together nearly 250 representatives from over 100 clinical […]
3 News Las Vegas: Global Alzheimer’s Platform Foundation event happening at Red Rock Casino
by Chloe KoastTue, February 24, 2026 at 9:36 AM From February 25th through the 27th the Global Alzheimer’s Platform Foundation will meet up at the Red Rock Casino Resort & Spa. More than 250 representatives are coming together to not only network but also share their dedication to find the cure for Alzheimer’s. This includes announcing a new […]
Medical Product Outsourcing: Could a Finger Prick Blood Test Help Diagnose Alzheimer’s?
The disease currently is diagnosed using expensive scans and lumbar punctures or spinal taps. February 18, 2026 By: Michael Barbella Managing Editor Alzheimer’s disease detection could be quite literally at our fingertips. A major international research project is underway at the U.K. Dementia Research Institute (DRI) to test whether a finger prick-style blood test could be […]
Providence Journal: Could a blood test detect Alzheimer’srisk? A RI company wants to know.
Diagnosing the disease can be expensive, invasive and complicated. Research in RI could help speed up the process Feb. 5, 2026, 5:04 a.m. ETEAST PROVIDENCE – Alzheimer’s, a neurodegenerative disease, is the primary cause of dementia in the United States. In Rhode Island, more than one in 10 adults over age 65 – about 22,000 […]
GAP Statement on “Interchangeability of blood-based biomarkers and PET to identify Alzheimer’s disease pathology”
“Changes in memory and cognitive health can start decades before symptoms appear. That’s why early diagnosis and intervention are crucial to slowing impact. A new paper co-authored by GAP with our partners at Eli Lilly and Company, “Interchangeability of blood-based biomarkers and PET to identify Alzheimer’s disease Pathology” published in Alzheimer’s & Dementia shows that blood biomarkers (P-tau 217 and Precivity AD) have high agreement with […]
GAP Statement on Recent Bio-Hermes-001 Publication in Alzheimer’s & Dementia
“We’re pleased and proud to report our latest paper using Bio-Hermes-001 data has been published in Alzheimer’s & Dementia. Many thanks to the co-authors who helped to bring this research article to light including Richard Mohs, Douglas Beauregard, Lynne Hughes, Cyndy Cordell, Allan Levey, M.D., Ph.D., Saima Rathore, Nicholas Seyfried, Erik Johnson, Jessie Nicodemus-Johnson, Joshua Christensen, and Robin […]
Neurology Advisor: CTAD 2025: Highlights in Alzheimer Disease Research
Tori Rodriguez, MA, LPC, AHC Publish DateJanuary 27, 202 At the 18th Annual Clinical Trials on Alzheimer’s Disease (CTAD) conference, held December 1 to 4, 2025, in San Diego, California, researchers presented new data spanning observational studies, biomarker analyses, and clinical development programs in Alzheimer disease (AD). Key topics included emerging evidence on metabolic therapies such as […]
Las Vegas site joins global study on Alzheimer’s blood test
by News 3 Staff,Updated Fri, January 23, 2026 at 1:20 PM LAS VEGAS (KSNV) — Clinical Neurology Specialists (CNS) in Las Vegas is participating in a groundbreaking international study sponsored by the Global Alzheimer’s Platform Foundation. The Bio-Hermes-002 study seeks volunteers with memory concerns to help identify blood or digital tests that could predict the presence of amyloid […]